ACP
AIMT

Acuta Capital Partners’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Acuta Capital Partners’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-58,525
Closed -$1.45M – 71
2017
Q3 		$1.45M Buy
+58,525
New +$1.45M 0.26% 28